Please provide your email address to receive an email when new articles are posted on . Semaglutide benefits were observed for adults with type 2 diabetes and chronic kidney disease whether or not ...

Please provide your email address to receive an email when new articles are posted on . Semaglutide lowered risk for kidney outcomes consistently across BMI subgroups in the FLOW trial. Body weight ...

New data from the landmark FLOW trial, which linked the glucagon peptide 1 (GLP-1) receptor agonist semaglutide with significant kidney outcomes in patients with type 2 diabetes (T2D) and chronic ...

According to a study published in The Lancet in 2020, there were an estimated 697.5 million cases of kidney disease worldwide ...

Our kidneys do a tremendous amount of work. Every day, they filter about 150 quarts of blood, cleaning it of waste, toxins and extra water. They regulate how much fluid is in the body and balance our ...

While painkillers, especially non-steroidal anti-inflammatory drugs (NSAIDs), can provide relief from pain and inflammation, ...